methylphenidate transdermal
Selected indexed studies
- Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents. (CNS Drugs, 2011) [PMID:21425884]
- Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS). (CNS Drugs, 2014) [PMID:24532028]
- Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. (Expert Rev Clin Pharmacol, 2011) [PMID:22114778]
_Worker-drafted node — pending editorial review._
Connections
methylphenidate transdermal is a side effect of
Sources
- Prescription of Controlled Substances: Benefits and Risks. (2026) pubmed
- Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents. (2011) pubmed
- Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS). (2014) pubmed
- Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. (2011) pubmed
- Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children. (2006) pubmed
- Methylphenidate transdermal system. (2005) pubmed
- Transdermal methylphenidate system: old wine in a new bottle. (2009) pubmed
- Evolution of stimulants to treat ADHD: transdermal methylphenidate. (2009) pubmed
- Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system. (2006) pubmed
- Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. (2008) pubmed